Catalent is a global leader in providing integrated services, superior drug delivery technologies and manufacturing solutions to help life science innovators develop and launch successful pharmaceuticals, biologics and consumer health products. They have built an advanced range of technologies and capabilities and are dedicated to enabling a better and faster customer journey from product development to patient.
With over 85 years of experience in the industry, Catalent supports their partners in introducing 200 new products and manufacturing over 70 billion doses each year. They became a publicly traded company (NYSE: CTLT) in 2014 and have grown to become a vibrant community of approximately 15,000 employees, including around 2,400 scientists and technicians, supporting over 7,000 products for over 1,000 customers all around the world. At Catalent, they share a common goal, to put patients first and help people around the world live better and healthier lives.